Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Beyond Air Inc XAIR

Healthcare Medical Devices
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Company’s LungFit platform can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections through... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:XAIR)

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting

GlobeNewswire 4 days ago

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

GlobeNewswire March 20, 2024

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

GlobeNewswire February 12, 2024

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

GlobeNewswire January 18, 2024

Beyond Cancer(TM) Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

GlobeNewswire December 27, 2023

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire November 15, 2023

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

GlobeNewswire November 13, 2023

Beyond Cancer(TM) Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

GlobeNewswire November 3, 2023

Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast

GlobeNewswire October 19, 2023
View More News ››

Opinion & Analysis (NDAQ:XAIR)

Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment

Streetwise Reports June 18, 2020
View More Opinion ››

Bullboard Posts (NDAQ:XAIR)

phase 1 study

 Beyond Air affiliate Beyond Cancer doses patient in phase 1 study of ultra-high concentration nitric oxide therapy Beyond Air...
Red~One - August 23, 2022

Nitric Oxide in the News

Canadian company SaNOtize’s COVID-19 treatment wins approval in India A treatment for COVID-19 that was developed in British Columbia has...
Red~One - February 11, 2022

News

Not quite the news that we had hoped for but a nice buying opp, wonder where it will settle out
Red~One - December 9, 2021

BEYOND AIR: STRONG UPCOMING CATALYSTS MAKE THIS A MUST WATCH

Beyond Air (NASDAQ:XAIR) is a clinical-stage biopharmaceutical and medical device company that uses a proprietary technology to produce...
AviseAnalytics - August 30, 2021
View more Bullboard ››

Fintech Select Ltd.

Fintech Select Ltd.

Fintech Select is a provider of pre-paid card programs, an online payment platform, and a POS cryptocurrency platform that ...
View More »